首页 | 本学科首页   官方微博 | 高级检索  
     


Subject index
Abstract:
Keywords:A3243G mutation  ABPM  acrodermatitis chronica atrophicans  acute ischemic neurological event  adhesion molecules  ageing  aging  Alzheimer's disease  amino acids  amyotrophic lateral sclerosis  angiogenesis  antibodies  anti‐ganglioside antibody  anti‐GM1 antibodies  antihypertensive therapy  arterial hypertension  arterio‐jugular venous difference of oxygen  artery‐to‐artery embolism  astheno‐emotional disorder  astrocyte  atrial fibrillation  atrial natriuretic peptide  atrio‐ventricular block  auditory brainstem response  autonomic function  blood pressure  Borrelia  Boston questionnaire  brain dysplasia  brain natriuretic peptide  brain tumor  branched‐chain amino acid therapy  calcium  carbon disulfide  cardiac arrhythmias  caregivers  carpal tunnel syndrome  cataract  central nervous system involvement  cerebral circulation  cerebral embolism  cerebral infarction  cerebrospinal fluid  cerebrovascular reactivity  cholesterol  chronic  chronic acquired hepatocerebral degeneration  clinical characteristics  clinical severity scale  cognition  cold pressor test  Commission Report  compound muscle action potentials  computerized tomography scan  congenital muscular dystrophy  coping  corpus callosum  cranial nerves  CSF  dementia  dentatorubral‐pallidoluysian atrophy (DRPLA)  diabetes mellitus  diagnosis of epilepsy  diffusion‐weighted MRI  dopamine agonist  Doppler  dosing  double discharges  dystonia  early diagnosis  eclampsia  EEG reporting  electrodiagnosis  electroencephalography  ELISA  embolism  enoxaparin  epidemiology  epilepsy  epilepsy surgery  epileptic seizures  essential tremor  estrogen receptor 1  European Guidelines  excitatory and inhibitory amino acids  fasciculation potentials  flow cytometry  fukutin gene  Fukuyama disease  gene  glycemic control  GM1 ganglioside  GT1a  Guillain–Barré syndrome  head tremor  head‐up tilt  health‐related quality of life  hepatocyte growth factor  hereditary spastic paraplegia  high‐sensitive C‐reactive protein  human  human herpes virus 6  Huntington's disease  hypercoagulability  hyperexcitability  hypothermia  IgG  immunosupressive therapy  inflammation  interferon‐β 1a  interleukin‐12  ischaemic stroke  jugular venous oxygen saturation  lactic acidosis and stroke‐like episodes  Leber's hereditary optic neuropathy (LHON)  lipoproteins  long‐term follow‐up  low‐dose  low‐molecular‐weight heparin  Lyme disease  lymphocyte subsets  lysophosphatidylcholine  magnetic resonance imaging  magnetoencephalography  MELAS  memory  methodology  middle cerebral artery  middle‐latency response  mild cognitive impairment  mitochondrial DNA  mitochondrial encephalomyopathy  mitoxantrone  motoneuron  motor nerve conduction velocity  multifocal motor neuropathy  multimodality MRI  multiple  multiple sclerosis  muscle force  myasthenia gravis with hyperthyroidism  neuroborreliosis  neurofibroma  neurofibromatosis  neurofibromin  neurological symptoms  neuropathy  neuropsychological effects  neuropsychology  normal pressure hydrocephalus  olanzapine  oligodendroglioma  outcome  organic psychiatric disorders  outcome  painful neuropathy  parkinsonism  Parkinson's disease  partial‐onset  patient satisfaction  PCDD  peripheral nerve  pharyngeal cervical‐brachial variant  phosphatidylcholine  plasma  polychlorinated dioxins  polymerase chain reaction  polymorphism  prevalence  progressive supranuclear palsy  resource utilization  Riluzole  ropinirole  secondary hyperparathyroidism  seizure  serum  severe subarachnoid hemorrhage  shunt surgery  siblings  simultanagnosia  single photon emission computed tomography  skeletal muscle  slow cortical potential  small  sodium valproate  somatosensory‐evoked potential  sPECAM‐1  spinocerebellar ataxia type 6  spinocerebellar degeneration  sPLA2  stenosis  stroke  subarachnoid hemorrhage  sudden unexpected death associated with epilepsy  surgery  surgical decompression  synaptosome  syndrome  TCDD  TGF‐β1  therapeutics  thromboprophylaxis  thyroid gland  tick‐borne encephalitis  topiramate  transcranial  transcranial Doppler  transforming growth factor‐β1  treatment  treatment outcome  tumour supressor gene  ultrasonography  visual recovery  white matter damage
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号